ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615985 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615985; 2) Community: the network communities that were significantly associated with the response to NSC 615985; 3) Molecule: the relationships between components within communities and NSC 615985; 4) MDR: the compounds that were significantly associated with the NSC 615985.

NSC Compound Enrichment Correlation
NSC 249956 CHAPLIATRIN 0.0474314077111082 0.35240596
NSC 253272 Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) 0.0474314077111082 0.4511988
NSC 668261 Null 0.0476261779267962 0.4055871
NSC 735181 (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl 4-methylpiperazine-1-carbodithioate 0.0476261779267962 0.59290341
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.048939380959983 0.092127003
NSC 19441 FDA 0283 0.048939380959983 0.014184963
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.048939380959983 0.073623702
NSC 59620 (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate 0.048939380959983 0.41001709
NSC 59996 Benzaldehyde, 2-amino-, phenylhydrazone (9CI) 0.048939380959983 0.18233526
NSC 658292 Null 0.0489393809599837 0.061724163
Total:76  Current:73    [First] [Prev] [Next] [Last]